Abstract:BACKGROUND/PURPOSE: Oral lichen planus (OLP) is a localized autoimmune oral mucosal disease. This study evaluated whether different types of OLP patients including erosive OLP (EOLP), major EOLP, minor EOLP, and non-erosive OLP (NEOLP) patients had significantly higher percentages of FoxP3+CD4+ or IFN-γ+CD4+ cells in total CD4+ cells, and of IFN-γ+CD8+ cells in total CD8+ cells than healthy control subjects and whether the patient's age had significant influences on these cell percentages in OLP patients.MATERIALS AND METHODS: Flow cytometry was used to count the FoxP3+CD4+, IFN-γ+CD4+, or IFN-γ+CD8+ cell levels in 183 OLP patients (67 major EOLP, 81 minor EOLP, and 35 NEOLP patients) and 20 healthy control subjects.RESULTS: Major EOLP patients had a significantly higher FoxP3+CD4+ cell percentage than health control subjects (P = 0.049) or minor EOLP patients (P = 0.008). Major EOLP patients had a significantly higher IFN-γ+CD4+ or IFN-γ+CD8+ cell percentage than healthy control subjects, NEOLP patients, or minor EOLP patients (all P-values < 0.01). In addition, both 61-80 year and 41-60 year OLP patients had significantly higher IFN-γ+CD8+ cell percentages than healthy control subjects or 20-40 year OLP patients (all P-values < 0.005).CONCLUSION: Major EOLP patients tend to have significantly higher percentages of FoxP3+CD4+, IFN-γ+CD4+, and IFN-γ+CD8+ cells than healthy control subjects, NEOLP patients or minor EOLP patients, suggesting that FoxP3+CD4+ Treg cells are increased to modulate OLP disease activity. Increased number of IFN-γ-producing activated T cell may be involved in oral epithelial cell destruction in OLP patients.

Immunohistochemical analysis of the expression of selected cell lineage markers (CD4, CD8, CD68, c‐Kit, Foxp3, CD56, CD20) in cutaneous variant of lichen planus

Distinct Variations in Gene Expression and Cell Composition across Lichen Planus Subtypes

Expression of Foxp3 and interleukin-17 in lichen planus lesions with emphasis on difference in oral and cutaneous variants

Lichen Striatus Versus Linear Lichen Planus: A Comparison Of Clinicopathological Features, Immunoprofile Of Infiltrated Cells, And Epidermal Proliferation And Differentiation

CXCL9, CXCL10, and CCL19 synergistically recruit T-lymphocytes to skin in lichen planus

Increased expression of psoriasin (S100A7) and interleukin 17 (IL-17) in lesional skin in lichen planopilaris

Langerhans Cells, T Cells, and B Cells in Oral Lichen Planus and Oral Leukoplakia

Immunoexpression of Interleukin-22 and Interleukin-23 in Oral and Cutaneous Lichen Planus Lesions: a Preliminary Study.

Immuohistochemical Comparison of Infiltrating Cells among Mycosis Fungoides, Lichen Planus and Psoriasis

FoxP3+CD4+, IFN-γ+CD4+, and IFN-γ+CD8+ cell levels in erosive and non-erosive types of oral lichen planus patients

Assessment of PD-1 and PD-L1 tissue expression levels in lichen planus patients: a case–control study

Checkpoint inhibitor-induced lichen planus differs from spontaneous lichen planus on the clinical, histological, and gene expression level

Single-cell immune profiling reveals immune responses in oral lichen planus

B Cells Infiltration Potentially Responded Better to Systemic Corticoids in Oral Lichen Planus and Oral Lichenoid Lesions

Immunohistochemical Expression of Immune Regulatory Proteins in Interface Dermatoses

Altered expression of CCN1 in oral lichen planus associated with keratinocyte activation and IL-1, ICAM1, and CCL5 up-regulation

Foxp3 gene expression in oral lichen planus: a clinicopathological study.

Altered expression of CCN1 in oral lichen planus associated with keratinocyte activation and IL-1β, ICAM1 and CCL5 up-regulation.

Wnt5a Is Involved In The Pathogenesis Of Cutaneous Lichen Planus

Expression of regulatory T cells and Helper T cells 17 in the lesion tissue of oral lichen planus

Expression of Foxp3 + regulatory T cells in oral lichen planus